The rise of China and India, combined with protectionist pressure from the Trump administration, is redrawing the global map ...
With demand for its RNA interference meds booming, Alnylam Pharmaceuticals has commenced work to soup up its flagship ...
Low compliance by the country’s 8,500 small and medium enterprises (MSMEs) manufacturing pharmaceuticals would raise the risk ...
New addition enhances manufacturing continuity and supports seamless progression from early-phase development to late-stage ...
Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...
Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making ...
Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.
The year 2025 was defined by escalating global trade tensions that fundamentally reshaped the pharmaceutical supply chain, ...
Sun Pharma highlights obesity treatment drugs as a growth driver for India's pharma industry, enhancing access to GLP-1 ...
Preclinical research is crucial for the development of any novel drug. It demands significant resources that are often expensive and inaccessible to biotechnology and pharmaceutical companies of all ...
Its unwavering commitment to quality, combined with our streamlined production methods, has led to outstanding results as we work together to address the country’s public health needs." Kamran Butt, ...
Stockhead on MSN
Culture testing is becoming pharma’s next battleground, and Clever Culture has a head start
Clever Culture is quietly automating one of pharma’s most unforgiving jobs , turning a regulatory headache into a scalable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results